PBS Newshour reports: The refusal to grant protection for Abbott means generic-drug companies can continue selling copies of the medication at a fraction of the price to the developing world.
PBS Newshour reports: The refusal to grant protection for Abbott means generic-drug companies can continue selling copies of the medication at a fraction of the price to the developing world.
Partner with us now to build
a more just and equitable
medicine system for all.